2019

ADmit Therapeutics receives strong boost from competitive aid

Innovation, Neurologic Diseases and Neurogenetics , Neuropathology, Neuroscience Program / By

The company ADmit Therapeutics S.L. The spin-off of the Bellvitge Biomedical Research Institute (IDIBELL) that works toward developing a test for the early detection of Alzheimer’s disease (AD), has just received two important sources of funding through competitive calls from the Spanish  Ministry of Science, Innovation and Universities. Specifically, he has been awarded a Torres …

ADmit Therapeutics receives strong boost from competitive aid Read More »

Innovation for value analyzes the use of big data and the new power it gives to patients

Innovation / By

The conference on health innovation Innovation for value, held on November 8 in Barcelona, ​​has analyzed the opportunities offered by technological advances in the field of health. The conference, organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), has been attended by some of the …

Innovation for value analyzes the use of big data and the new power it gives to patients Read More »

Successful informative session on U.S. Non-dilutive funding at IDIBELL

Leave a Comment / Uncategorised / By

The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S. funding sources for Health Projects, that were delivered by Dr. Ana Turchetti-Maia, Director of Business Development at Freemind …

Successful informative session on U.S. Non-dilutive funding at IDIBELL Read More »

The consul general of France in Barcelona visits IDIBELL

Leave a Comment / Hereditary cancer , Radiobiology & Cancer / By

The consul general of France in Barcelona, Cyril Piquemal, visited IDIBELL on October 23rd in order to get to know the institute and promote collaborations and synergies with French institutions. The visit took place as part of the efforts made by the French consulate to strengthen the interaction between research centers in Catalonia and France. …

The consul general of France in Barcelona visits IDIBELL Read More »

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

Leave a Comment / Modeling human diseases in C. elegans , Traslacional Medicine / By

At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000. …

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells Read More »

Scroll to Top